Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Scarpelli

Showing results (1-10 of 296) with videos related to

Pageof 30
Sort By:
The Journal of Urology|February 28, 2018
Editorial CommentRodolfo Montironi, Marina Scarpelli
The Journal of Urology|July 9, 2019
Editorial CommentRodolfo Montironi, Marina Scarpelli
Archives of Pathology & Laboratory Medicine|April 3, 2020
From Undergraduate Medical School Student to Visible PathologistRodolfo Montironi, Alessia Cimadamore, Marina Scarpelli
Annals of the New York Academy of Sciences|July 4, 2002
Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemopreventionRodolfo Montironi, Roberta Mazzucchelli, Marina Scarpelli
European Urology|September 23, 2003
Molecular techniques and prostate cancer diagnosticRodolfo Montironi, Roberta Mazzucchelli, Marina Scarpelli
Virchows Archiv : an International Journal of Pathology|March 27, 2004
Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptorsRodolfo Montironi, Marina Scarpelli, Antonio López Beltran
European Urology Focus|May 17, 2021
Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017: Focus on Our Personal Recollections and ObservationsRodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, et al.
Current Drug Targets|January 24, 2020
Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring AlgorithmsFrancesca Giunchi, Thomas Gevaert, Marina Scarpelli, et al.
European Urology|January 1, 2013
Words of wisdom: re: multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspectsRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, et al.
European Urology|April 11, 2021
Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489-91Alessia Cimadamore, Antonio Lopez-Beltran, Marina Scarpelli, et al.
Pageof 30

Showing results (1-10 of 296) with videos related to

Sort By:
Pageof 30
The Journal of Urology|February 28, 2018
Editorial CommentRodolfo Montironi, Marina Scarpelli
The Journal of Urology|July 9, 2019
Editorial CommentRodolfo Montironi, Marina Scarpelli
Archives of Pathology & Laboratory Medicine|April 3, 2020
From Undergraduate Medical School Student to Visible PathologistRodolfo Montironi, Alessia Cimadamore, Marina Scarpelli
Annals of the New York Academy of Sciences|July 4, 2002
Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemopreventionRodolfo Montironi, Roberta Mazzucchelli, Marina Scarpelli
European Urology|September 23, 2003
Molecular techniques and prostate cancer diagnosticRodolfo Montironi, Roberta Mazzucchelli, Marina Scarpelli
Virchows Archiv : an International Journal of Pathology|March 27, 2004
Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptorsRodolfo Montironi, Marina Scarpelli, Antonio López Beltran
European Urology Focus|May 17, 2021
Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017: Focus on Our Personal Recollections and ObservationsRodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, et al.
Current Drug Targets|January 24, 2020
Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring AlgorithmsFrancesca Giunchi, Thomas Gevaert, Marina Scarpelli, et al.
European Urology|January 1, 2013
Words of wisdom: re: multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspectsRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, et al.
European Urology|April 11, 2021
Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489-91Alessia Cimadamore, Antonio Lopez-Beltran, Marina Scarpelli, et al.
Pageof 30